Clinical Trials for Phost'in Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Phost'in Therapeutics

Clinical Trials (1)

NCT05495295
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
PHASE1Recruiting
149 participants
Started: Jul 18, 2022 · Completed: Jul 31, 2027
4 conditions1 sponsor4 locations